Tovetumab

Tax included
Tovetumab (MEDI-575) is an anti-PDGFRα monoclonal antibody that selectively blocks the PDGFRα signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC).
MedChemExpress 
HY-P99223

Data sheet

Size
Multiple sizes
Reactivity
PDGFR
Application
Cancer-Kinase/protease
CAS
1243266-04-7